-
Mashup Score: 0
In 2021, the USPSTF changed guidance on colorectal cancer screenings, reducing the recommended age of a colonoscopy from 50 to 45 years.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0
As the treatment paradigm for neurologic diseases rapidly progresses, the need for more thorough biomarker tools to measure disease progression and severity has increased. In recent years, GFAP has emerged as a valuable candidate to add to the existing panel.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
From our sister site @neurology_live: GFAP blood biomarker is an emerging diagnostic asset in neurological disease. But as the field continues to evolve, its truest utility is still unknown. #ThisYearInMedicine https://t.co/HUKcSSXpKq
-
-
Mashup Score: 0
Eyes with bacillary detachment had higher fluid volumes, increased CST, EZ attenuation, and increased sub-RPE volume at baseline.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
Bacillary detachment is an OCT signature that is identifiable in a significant proportion of eyes with #nAMD, new findings say. https://t.co/EJqT8aO9qo
-
-
Mashup Score: 1
Close to half of patients with wet AMD treated with aflibercept could safely stop eye injection therapy after one year without further vision loss, according to the pilot study.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
Compared to bevacizumab, nearly half of patients with wet #AMD treated with aflibercept could safely stop injection therapy after one year without further #vision loss. https://t.co/2UikNMjpkQ
-
-
Mashup Score: 0
After decades of unmet needs in the progressive form of vision loss, the complement inhibitor drug class is nearing the market for affected patients.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
This Year in Medicine: Our final piece for today's #ophthalmology specialty day focuses on new treatments in geographic atrophy and how the battle to save sight has entered a new era in 2022, featuring expert insight. #TYIM https://t.co/4csD92kJSj
-
-
Mashup Score: 0
A look back at 2022, including new drug approvals, the significance of treatment for geographic atrophy, and what the future holds within the retina space. Veeral Sheth, MD joins to discuss in a Q&A.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
Veeral Sheth, MD @URetina joins for a look back at 2022 in #ophthalmology, including new drug approvals, the significance of new treatment options for GA, and the future of retina care. https://t.co/W3MEeWTTR2
-
-
Mashup Score: 0Inequities Continue to Exist in Ophthalmology Care - 1 year(s) ago
Individuals living in lower-income situations were also more likely to have vision impairment, use eye care services less, and have lower adherence to eye examinations.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
A closer look at the inequities in ophthalmology show there are major gaps and hurdles for minorities that lead to major societal costs and worse ophthalmologic outcomes. #ophthalmology https://t.co/J28kK4hei7
-
-
Mashup Score: 0
Dr. Glasser shares perspective on the adoption of telehealth in ophthalmology and the importance of increased funding to provide sufficient reimbursement for all physician services.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
A new Q&A with David Glasser, MD @HopkinsMedicine focuses on the future of telehealth in #ophthalmology and the need to address reimbursement challenges of new technologies. Check it out here: https://t.co/C5mgcm8R2Q
-
-
Mashup Score: 0
Macular holes in stage 2 progress faster than those in stages 3 and 4, making it beneficial to perform vitrectomy without delay in this population.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
New research finds #macular holes in stage 2 progress faster than those in stages 3 and 4, making it beneficial to perform vitrectomy without delay in this population. #ophthalmology https://t.co/PfOhIE0nJE
-
-
Mashup Score: 0
New research highlights the growing number of claims among all providers, including advanced practice practitioners and non-dermatologists, of Cal/BD foam usage for Medicare beneficiaries.
Source: HCPLive®Categories: General Medicine News, Latest HeadlinesTweet-
New research highlights the growing number of claims among all providers, including advanced practice practitioners and non-dermatologists, of Cal/BD foam usage for #Medicare beneficiaries with #psoriasis: https://t.co/yWShkZV0Tu
-
Colon cancer screening rates took a major hit during #COVID19. But now, recommendations have altered and tools have advanced. Where do we stand in 2022? Our latest from #ThisYearInMedicine: https://t.co/u5DztLfZnn